Mechanisms of autoantibody-mediated thrombosis

Lupus

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Roubey, R A S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiphospholipid syndrome; Endothelial cells; Monocytes; Platelets; Protein C; Thrombosis; 2 glycoprotein I

Indexed keywords

ANTIGEN; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CELL SURFACE RECEPTOR; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTHROMBIN;

ANTIPHOSPHOLIPID SYNDROME; CELL ACTIVATION; CONFERENCE PAPER; CROSS LINKING; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS;

EID: 0031762606     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339800700226     Document Type: Conference Paper

References (32)

1. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-3073
2. Branch DW, Dudley DJ, Mitchell MD. IgG fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obset Gynecol 1990, 163: 210-216.
3. Pierangeli SS et al. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-1367.
4. 2-glyoprotein I. J Clin Invest 1992; 90: 1100-1104.
5. 2-glycoprotein 1 complexes to lipid membranes Biochemistry 1996; 35: 13833-13842.
6. Arnout J et al Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces. Thromb Haemost 1998; 79: 79-86.
7. Comp PC, DeBault LE, Esmon NL, Esmon CT. Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants. Blood 1983; 62 (Suppl 1): 299a (Abstract).
8. Marcimak E, Romond EH. Impaired catalytic function of activated protein C a new in vitro manifestation of lupus anticoagulant. Blood 1989, 74: 2426-2432
9. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990, 79 101-107.
10. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C, or protein S an explanation for their pathogenic mechanism? Blood 1993, 81 2618-2625.
11. Halbmayer W-M, Haushofer A, Schön R, Fischer M. Influence of lupus antibodagulant on a commercially available kit for APC-resistance. Thromb Haemost 1994, 72 645-646
12. 2-glycoprotein I inhibits the thrombin/thrombomodulin dependent activation of protein C Blood 1991, 78: 184a (Abstract).
13. Oosting JD et al. In vitro studies of antiphospholipid antibodies and its cofactor. beta-2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation Thromb Haemost 1991, 66: 666-671.
14. 2-glycoprotein I antibody on factor Va degradation by activated-protein C and its cofactor protein S Am J Hematol 1995, 49: 89-91.
15. Shibata S et al. Autoantibodies to haparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes Blood 1994: 83: 2532-2540.
16. 2-glycoprotein I of the factor Xa generating activity of platelets Thromb Haemost 1993, 70: 342-345
17. Rand et al Reduction of annexin-V (placental anticoagulant protein-1) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994; 171: 1566-1572
18. Rand JH et al Pregnancy loss in the antiphospholipid-antibody syndrome - A possible thrombogenic mechanism. N Engl J Med 1997, 337: 154-160.
19. Violi F et al Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. Br Med J 1990; 300: 1099-1102.
20. Sanfelippo MJ, Drayna CJ. Prekallikrein inhibition associated with the lupus anticoagulant, a mechanism of thrombosis. Am J Clin Pathol 1982; 77: 275-279
21. 1-esterase inhibitor levels in patients with lupus inhibitor Am J Clin Pathol 1987; 88: 223-228.
22. 2-glycoprotein I. Thromb Haemost 1995; 73: 798-804
23. Kornberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies J Immunol 1994, 153: 1328-1332.
24. Cuadrado MJ et al. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997, 40. 834-841.
25. Ginsberg JS et al Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodie: evidence for a prothromobite state. Blood 1993, 81: 2958-2963.
26. Costing JD et al. Antiphospholipid antibody positive sera enhanced endothelial cell procoagulant activity-studies in a thrombosis model. Thromb Haemost 1992; 68: 278-284.
27. 2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179-185
28. Simantov R et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995, 96: 2211-2219.
29. Carreras LOThe lupus anticoagulant and eicosanoids Prostaglandins Leukot Essent Fatty Acids 1993; 49: 483-488.
30. Lellouche F et al. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant Blood 1991; 78: 2894-2899
31. Martinuzzo ME, Maclouf J, Carreras LO, Lévy-Toledano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost 1993; 70: 667-671.
32. 2-glycoprotein I. Throm Haemost 1993, 70. 336-341.